CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Lantern Pharma Receives US Patent Allowance for Cancer Drug LP-184

Patent ExpiryLP-184Positive
AI Analysis

Summary

Lantern Pharma received a US patent allowance for its cancer drug LP-184, strengthening its intellectual property position for the asset.

Outcome Details

US Patent allowance received

Importance:4/10
Sentiment:
0.60
patentoncologyintellectual_property
Related Companies

Read the original article

Published by yahoo_finance on July 23, 2026 12:57 PM

Read Original